Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   26 Sep 16 | 03:43 PM

393.15 -1.8 (-0.46%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   26 Sep 16 | 03:31 PM

394.05 -0.75 (-0.19%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 387.10 (1.56%)
1 Month : Rs 380.95 (3.20%)
1 Year : Rs 407.90 (-3.62%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Coal India332.651.19
Reliance Inds.1,109.350.58
Lupin1,495.050.42
Dr Reddy's Labs3,191.450.33
TCS2,400.850.15

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine